English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 904027 Online Users : 793
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
生技與藥物研究所
謝興邦
--專利
--期刊論文
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
生技與藥物研究所
>
謝興邦
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
謝興邦(Hsing-Pang Hsieh)
ORCID:0000-0002-1332-005X6
Loading...
Collection
專利
[
0
/42]
期刊論文
[
141
/141]
會議論文/會議摘要
[
30
/48]
Siblings
伍素瑩
[
52
/65]
其他
[
58
/60]
夏克山
[
76
/98]
岳嶽
[
29
/32]
張仲明
[
7
/9]
張俊彥
[
18
/18]
張竣評
[
21
/26]
徐祖安
[
170
/215]
李秀珠
[
75
/105]
李靜琪
[
23
/24]
林書玉
[
19
/20]
洪明秀
[
31
/40]
潘秀玲(2009-2013)
[
16
/17]
王文傑
[
13
/15]
王鴻俊
[
7
/7]
石全(2014-2017)
[
35
/39]
童俊維
[
23
/23]
紀雅惠
[
21
/25]
翁紹華
[
22
/24]
莊宏
[
1
/1]
葉修華
[
24
/25]
葉燈光
[
133
/152]
蔣維棠
[
41
/66]
趙宇生(2002-2013)
[
120
/212]
郭靜娟
[
49
/55]
鄒倫
[
28
/29]
陳志豪
[
31
/52]
陳新(2002-2015)
[
53
/67]
陳炯東
[
180
/212]
顏婉菁
[
6
/7]
許明珠(1997-2001)
[
3
/10]
陳淑貞(1998-2001)
[
3
/11]
陳華鍵(1997-2001)
[
9
/9]
Community Statistics
近3年內發表的文件:13(5.63%)
含全文筆數:171(74.03%)
文件下載次數統計
下載大於0次:171(100.00%)
下載大於100次:168(98.25%)
檔案下載總次數:101886(1.90%)
最後更新時間: 2024-12-01 03:15
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
DBPR116, a prodrug of BPRMU191, in ...
Discovery of dual MER/AXL kinase in...
Macrophage-mediated controlled rele...
Targeting cathepsin S promotes acti...
Discovery of novel AXL and MER inhi...
Influence of ring strain on the for...
A dual nociceptin and mu opioid rec...
Development of furanopyrimidine-bas...
A critical overview of current prog...
Recent advances in total synthesis ...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 101-125 of 231. (10 Page(s) Totally)
<<
<
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2013-01
Substituent effects on the photorearrangements of unsymmetrically substituted diazinobarrelenes
RSC Advances. 2013 Jan;3(4):1165-1178.
2012-12
An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold
Journal of the Chinese Chemical Society. 2012 Dec;59(12):1548-1554.
2012-09
Anti-influenza drug discovery: Identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization
ChemMedChem. 2012 Sep;7(9):1546-1550.
2012-08-24
Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts
PLoS ONE. 2012 Aug 24;7(8):Article number e43314.
2012-05-11
作為極光激酶抑制劑之稠合雙環嘧啶化合物
I363627/2012-05-11
2012-04-21
吡咯啉啶化合物
I362388/2012-04-21
2012-03-25
Design, synthesis, and SAR studies of duel FLT-3 and Aurora kinase inhibitors
Abstracts of Papers - American Chemical Society. 2012 Mar 25;243:Article number 48-MEDI.
2012-03-20
Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
US8138194B2/2012-03-20
2012-03-06
Indole compounds
CA2437104/2012-03-06
2012-02
Identification of BPR3P0128 as an Inhibitor of cap-snatching activities of influenza virus
Antimicrobial Agents and Chemotherapy. 2012 Feb;56(2):647-657.
2012-01-17
Pyrrolidine compounds
CA2559611/2012-01-17
2012-01
A High-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors
Anticancer Research. 2012 Jan;32(1):147-151.
2011-11-15
Coumarin compounds and their use for treating cancer
US8058427B2/2011-11-15
2011-09-23
BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo
European Journal of Cancer. 2011 Sep 23;47:S127.
2011-09
Synthesis and biological evaluation of 1-(4′-Indolyl and 6′-Quinolinyl) indoles as a new class of potent anticancer agents
European Journal of Medicinal Chemistry. 2011 Sep;46(9):3623-3629.
2011-09
Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway
Journal of Virology. 2011 Sep;85(17):9114-9126
2011-08
BPR1K653, a novel aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells
PLoS ONE. 2011 Aug;6(8):Article number e23485.
2011-07-11
抑制C型肝炎病毒感染之倍半帖內酯類化合物及其醫藥組成物
I344959/2011-07-11
2011-06-21
抑制冠狀病毒之醫藥組合物
I343809/2011-06-21
2011-06-21
抑制冠狀病毒之醫藥組合物
I343808/2011-06-21
2011-06-21
抑制冠狀病毒之醫藥組合物
I343810/2011-06-21
2011-06
Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10)
Expert Opinion on Therapeutic Patents. 2011 Jun;21(6):857-884.
2011-04-28
Scaffold-hopping strategy: Synthesis and biological evaluation of 5,6-Fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents
Journal of Medicinal Chemistry. 2011 Apr 28;54(8):3076-3080.
2011-04-06
Indole compounds as inhibitors of tubulin polymerisation for the treatment of angiogenesis related disorders
EP1506960/2011-04-06
2011-04
Antivascular activities of novel tubulin binding agent BPR0L075
Cancer Research. 2011 Apr;71:Abstract number 5309.
Showing items 101-125 of 231. (10 Page(s) Totally)
<<
<
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback